Colorectal cancer (CRC) is the second most common cancer-related cause of death in Canada. This high mortality rate is largely due to the lack of a cost-effective, patient-accepted and sensitive screening tool. Metabolomic Technologies Inc. (MTI) has developed a nuclear magnetic resonance (NMR)-based urinary diagnostic test for detecting colonic polyps (PolypDx™). Identification of adenomatous polyps […]
Read More